Concepedia
Statistics
Publications
7
Citations
295
H-Index
Active since
2020
Affiliations
Philochem (Switzerland)(Current)
ETH Zurich
Philogen (Italy)
University Hospital of Zurich
University of Trento
Lisa Nadal is an author at Philochem (Switzerland) specializing in oncology, targeted cancer therapy, and pharmacy.
Publications per year
2020–2022
An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications
Jacopo Millul, Gabriele Bassi, Jacqueline Mock et al. · Proceedings of the National Academy of Sciences · 2021 · 162 citations · Full text
Pharmacy, Medicinal Chemistry, Oncology +17
Selective tumor targeting enabled by picomolar fibroblast activation protein inhibitors isolated from a DNA-encoded affinity maturation library
Sara Puglioli, Eleonore Schmidt, Christian Pellegrino et al. · Chem · 2022 · 41 citations
Pharmacy, Medicinal Chemistry, Oncology +16
Generation and <i>in vivo</i> validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody
Lisa Nadal, Frederik Peissert, Abdullah Elsayed et al. · Journal for ImmunoTherapy of Cancer · 2022 · 26 citations · Full text
Pharmacy, Immunology, Oncology +17
Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid Tumors
Aureliano Zana, Andrea Galbiati, Ettore Gilardoni et al. · Clinical Cancer Research · 2022 · 23 citations
Medicine, Oncology, Pharmacology +17
The immunocytokine L19-TNF eradicates sarcomas in combination with chemotherapy agents or with immune check-point inhibitors
Riccardo Corbellari, Lisa Nadal, Alessandra Villa et al. · Anti-Cancer Drugs · 2020 · 17 citations
Medicine, Immunology, Oncology +17
1–5 of 7